metreleptin (Myalepta)

From Aaushi
Jump to navigation Jump to search

Indications

Contraindications

Dosage

  • 11.3 mg powder for injectable solution

Adverse effects

Mechanism of action

More general terms

References

  1. Medscape: Feb 25, 2014 Myalept (Metreleptin) Approved for Generalized Lipodystrophy. http://www.medscape.com/viewarticle/821056
  2. Chou K1, Perry CM. Metreleptin: first global approval. Drugs. 2013 Jun;73(9):989-97. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23740412
  3. 3.0 3.1 Brown T EMA Panel Recommends Metreleptin for Leptin Deficiency. Medscape - Jun 01, 2018. https://www.medscape.com/viewarticle/897471